Deracoxib
Specifications
169590-41-4CAS Number
807-307-6EC Number
4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)pyrazol-1-yl]benzenesulfonamideIUPAC Name
C17H14F3N3O3SChemical Formula
397.4 g/molMolecular Weight
Deracoxib; 169590-41-4; Deramaxx; 4-(3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl)benzenesulfonamide; SC 46; SC-59046; SC 59046; deracoxibum; DTXSID4045975; VX29JB5XWV; NSC-758935; 4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]benzenesulfonamide; DTXCID2025975; CHEBI:73032; Benzenesulfonamide, 4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]-; Benzenesulfonamide, 4-(3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl)-; Doxidyl; Rederox; Coxiba; OstiMax; OstiMax Chewable; Deracoxib Chewable; DOXIDYL Chewable; RefChem:54945; Deramaxx Chewable Tablets; Deracoxib Chewable Tablets; 807-307-6; C17H14F3N3O3S; SC 046; MFCD09837763; Deracoxib [USAN]; Deram; CHEMBL28636; Deracoxib (USAN); 4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)pyrazol-1-yl]benzenesulfonamide; NCGC00095312-01; CAS-169590-41-4; Deracoxib [USAN:INN]; UNII-VX29JB5XWV; SC-046; DERACOXIB [INN]; DERACOXIB [MI]; Spectrum2_000521; Spectrum3_001677; Spectrum4_001227; Spectrum5_001644; DERACOXIB [WHO-DD]; SCHEMBL24645; BSPBio_003493; KBioGR_001694; SPBio_000501; DERACOXIB [GREEN BOOK]; orb1225964; orb1310568; SCHEMBL29593653; KBio3_002713; EX-A887; GLXC-06319; HMS2093M12; HMS3886O18; Pharmakon1600-01505222; UWC78024; Tox21_111503; BDBM50057583; CCG-39562; MSK4067-100M; NSC758935; s5711; AKOS016009604; Tox21_111503_1; DB11395; FD21070; NSC 758935; 4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide; 4-[5-(3-Fluoro-4-methoxyphenyl)-3-(difluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide; NCGC00095312-02; NCGC00095312-04; NCGC00095312-08; AC-33031; AS-19558; HY-17509; SY102730; Deracoxib Solution in Methanol, 100ug/mL; SBI-0206729.P001; DB-348585; NS00040614; T0484; D03689; AB01563051_01; F237584; SR-05000001985; Q5261287; SR-05000001985-1; BRD-K68558722-001-02-4; BRD-K68558722-001-04-0; 4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxy-phenyl)pyrazol-1-yl]benzenesulfonamide; 4-[3-Difluoromethyl-5-(3-fluoro-4-methoxy-phenyl)-pyrazol-1-yl]-benzenesulfonamideSynonyms
